Our Gallery
Browse our collection of health & medical images and highlights
Molecular model of JAK2 kinase domain bound to a small molecule inhibitor
Diagram of JAK-STAT signaling pathway from cytokine receptor to gene transcription
Structural comparison of JAK1, JAK2, JAK3, and TYK2 pseudokinase domains
Rheumatoid arthritis joint inflammation before and after JAK inhibitor treatment
Chemical structure of tofacitinib (Xeljanz) JAK1/JAK3 selective inhibitor
STAT3 dimer bound to DNA response element, showing transcription factor activity
Flow cytometry data showing T-cell activation markers modulated by baricitinib
Yongbyon Yongbyon illustration of cytokine signaling network involving JAK pathways
Timeline of FDA-approved JAK inhibitors from tofacitinib (2012) to present